Asset Management One Co. Ltd. Buys 2,106 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Asset Management One Co. Ltd. raised its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 1.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 182,559 shares of the medical equipment provider's stock after acquiring an additional 2,106 shares during the quarter. Asset Management One Co. Ltd. owned about 0.05% of Intuitive Surgical worth $97,647,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ISRG. Bennett Selby Investments LP lifted its position in Intuitive Surgical by 3.9% during the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock worth $234,000 after buying an additional 17 shares in the last quarter. LVW Advisors LLC increased its position in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock valued at $756,000 after acquiring an additional 19 shares during the last quarter. Wesbanco Bank Inc. raised its holdings in Intuitive Surgical by 1.6% during the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after acquiring an additional 19 shares in the last quarter. Journey Strategic Wealth LLC boosted its position in Intuitive Surgical by 1.9% during the fourth quarter. Journey Strategic Wealth LLC now owns 1,039 shares of the medical equipment provider's stock valued at $542,000 after purchasing an additional 19 shares during the last quarter. Finally, FSM Wealth Advisors LLC grew its stake in Intuitive Surgical by 3.7% in the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock valued at $275,000 after purchasing an additional 19 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Remove Ads

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 408 shares of the company's stock in a transaction on Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. This represents a 53.61 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Amal M. Johnson sold 4,635 shares of the company's stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the sale, the director now directly owns 12,275 shares of the company's stock, valued at $6,955,015. This represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 6,348 shares of company stock valued at $3,587,582 in the last quarter. Company insiders own 0.90% of the company's stock.

Intuitive Surgical Stock Up 0.7 %

Shares of Intuitive Surgical stock traded up $4.16 during trading on Monday, reaching $595.55. The company's stock had a trading volume of 1,188,781 shares, compared to its average volume of 1,979,754. The firm has a market cap of $212.12 billion, a PE ratio of 92.91, a P/E/G ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The business's 50-day moving average price is $559.48 and its 200-day moving average price is $520.19.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent analyst reports. Stifel Nicolaus increased their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a "buy" rating in a report on Thursday, December 5th. Raymond James increased their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an "outperform" rating in a research note on Friday, January 24th. JPMorgan Chase & Co. lifted their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Truist Financial lifted their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a "buy" rating in a research report on Friday, January 24th. Finally, Wells Fargo & Company lifted their price target on Intuitive Surgical from $630.00 to $687.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.